Financials data is unavailable for this security.
View more
Year on year Champions Oncology Inc 's revenues fell -6.90%from 53.87m to 50.16m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a 36.38% reduction in net income from a loss of 5.34m to a larger loss of 7.28m.
| Gross margin | 44.27% |
|---|---|
| Net profit margin | -6.58% |
| Operating margin | -6.73% |
| Return on assets | -12.39% |
|---|---|
| Return on equity | -432.46% |
| Return on investment | -44.43% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Champions Oncology Inc fell by 7.50m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 6.14m for operations while cash used for investing totalled 836.00k.
| Cash flow per share | -0.1116 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.0244 |
|---|---|
| Tangible book value per share | -0.0491 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.6876 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 333.00 |
More ▼
